See every side of every news story

Published 3 months ago • loading... • Updated 3 months ago

Catalent, will Italy do business with anti-obesity drugs?

Summary by Vogon Today

With the acquisition of Catalent by Novo Holdings, parent company of the Danish laboratory Novo Nordisk, famous for its anti-diabetes drugs capable of fighting obesity, Italy, with the Anagni site, would also produce its share. But competitors protest… All the details The Catalent site in Anagni, in the province of Frosinone, already busy in recent years packing anti-Covid vaccines from Pfizer , AstraZeneca, J&J and Moderna, could soon change…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

3 Articles

All

Left

Center

Right

contractpharma.com

EU Approves Novo Holdings' Acquisition of Catalent

Novo Nordisk still expects the acquisition to be completed towards the end of 2024.

Read Full Article

Catalent, will Italy do business with anti-obesity drugs?

With the acquisition of Catalent by Novo Holdings, parent company of the Danish laboratory Novo Nordisk, famous for its anti-diabetes drugs capable of fighting obesity, Italy, with the Anagni site, would also produce its share. But competitors protest… All the details The Catalent site in Anagni, in the province of Frosinone, already busy in recent years packing anti-Covid vaccines from Pfizer , AstraZeneca, J&J and Moderna, could soon change…

Read Full Article

pharmaceutical-technology.com

Novo Holdings' acquisition of Catalent gains EC approval

Novo Holdings, the investment arm of the Novo Nordisk Foundation, has gained approval from the EC for its acquisition of Catalent.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right0Center0Last Updated3 months agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in 3 months ago on Monday, December 9, 2024.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content. Stay informed with comprehensive global news coverage all in one place. Subscribe now to compare different perspectives, identify biases, and stay ahead of algorithms